HOTH·44148G204·US·equity·Healthcare - Biotechnology
HOTH (HOTH THERAPEUTICS INC) is held by 12 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($180,028), UBS Group AG ($132,701), STATE STREET CORP ($53,728). Net institutional sentiment: Mixed.
See how HOTH's score breaks down across 4 SEC sources
No recent insider, activist, or congressional trades found for this stock
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer